BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37675509)

  • 21. BCL-3 overexpression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
    Rassidakis GZ; Oyarzo MP; Medeiros LJ
    Blood; 2003 Aug; 102(3):1146-7. PubMed ID: 12869493
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
    Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as retroperitoneal fibrosis.
    Hammer ST; Jentzen JM; Lim MS
    Hum Pathol; 2011 Nov; 42(11):1810-2. PubMed ID: 21658744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endobronchial ALK+ anaplastic large-cell lymphoma resembling asthma in a 13-year-old girl.
    Pavlov N; Pavlov V; Culić S; Armanda V; Siebert R; Lozić B; Forempoher G; Lukšić B; Perić I; Goic-Barisic I
    J Pediatr Hematol Oncol; 2013 Jan; 35(1):e4-6. PubMed ID: 23042012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
    Rigaud C; Knörr F; Brugières L; Woessmann W
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101444. PubMed ID: 36907641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaplastic large cell lymphoma, ALK-positive in very young children: A long-term follow-up of two cases and a review of the literature.
    Aladily TN; Khader M; Bustami N; Bazzeh F
    Malays J Pathol; 2022 Dec; 44(3):517-521. PubMed ID: 36591719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of t(2;5)(p23;q35) in anaplastic large-cell lymphoma by long-range nested polymerase chain reaction assay.
    Yin CC; Luthra R
    Methods Mol Biol; 2013; 999():217-22. PubMed ID: 23666701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ALK-positive anaplastic large cell lymphoma with TPM3-ALK translocation.
    Shin S; Kim J; Yoon SO; Kim YR; Lee KA
    Leuk Res; 2012 Jul; 36(7):e143-5. PubMed ID: 22591683
    [No Abstract]   [Full Text] [Related]  

  • 29. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
    Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
    Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALCL by any other name: the many facets of anaplastic large cell lymphoma.
    Irshaid L; Xu ML
    Pathology; 2020 Jan; 52(1):100-110. PubMed ID: 31706671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of minimal disseminated disease and immune response to NPM-ALK in Japanese children with ALK-positive anaplastic large cell lymphoma.
    Iijima-Yamashita Y; Mori T; Nakazawa A; Fukano R; Takimoto T; Tsurusawa M; Kobayashi R; Horibe K
    Int J Hematol; 2018 Feb; 107(2):244-250. PubMed ID: 29030834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
    Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
    J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
    Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukaemic phase as initial presentation of primary bone anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.
    Leung RY; Kwong YL
    Br J Haematol; 2012 Nov; 159(3):257. PubMed ID: 22957534
    [No Abstract]   [Full Text] [Related]  

  • 36. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
    Gru AA; Voorhess PJ
    Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
    Ahrendsen JT; Ta R; Li J; Weinberg OK; Ferry JA; Hasserjian RP; Meredith DM; Varma H; Sadigh S; Michaels PD
    Am J Clin Pathol; 2022 Aug; 158(2):300-310. PubMed ID: 35460414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary effusion anaplastic large cell lymphoma with indolent clinical course and IRF4/DUSP22 rearrangement: a case report expanding the spectrum of effusion-based lymphoma.
    Yuan CT; Cheng AL; Hou HA
    Virchows Arch; 2023 Mar; 482(3):641-645. PubMed ID: 35984488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma.
    Liang X; Branchford B; Greffe B; McGavran L; Carstens B; Meltesen L; Albano EA; Quinones R; Cook B; Graham DK
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):e209-13. PubMed ID: 23619105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
    Mossé YP; Lim MS; Voss SD; Wilner K; Ruffner K; Laliberte J; Rolland D; Balis FM; Maris JM; Weigel BJ; Ingle AM; Ahern C; Adamson PC; Blaney SM
    Lancet Oncol; 2013 May; 14(6):472-80. PubMed ID: 23598171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.